Apelin-Apelin受体轴在小鼠胆汁淤积模型中促进胆管细胞增殖和肝纤维化
研究探讨Apelin(APLN)-Apelin受体(APJ)轴在胆汁淤积中对胆管反应和肝纤维化的调控作用。在原发性硬化性胆管炎(PSC)样本中APLN血清水平和胆管APLN/APJ表达升高;小鼠胆管结扎(BDL)或Mdr2-/-模型中APLN水平升高,ML221(APJ拮抗剂)或APLN基因敲除可减轻胆管细胞增殖/衰老、肝脏炎症、纤维化和血管生成。体外实验表明APLN通过Nox4/ROS/ERK依赖信号诱导胆管细胞增殖,并通过细胞内ROS激活肝星状细胞。
要点
- PSC患者血清APLN水平及胆管APLN/APJ表达升高。
- ML221或APLN敲除减轻BDL和Mdr2-/-小鼠的胆管细胞增殖/衰老、炎症、纤维化和血管生成。
- APLN通过Nox4/ROS/ERK信号诱导胆管细胞增殖,并通过ROS激活肝星状细胞。
核心结论
- APLN-APJ轴通过Nox4/ROS/ERK依赖信号诱导胆管细胞增殖,并通过细胞内ROS激活肝星状细胞。
- 调控APLN-APJ轴可能对管理胆管病具有意义。
研究设计与样本
- 检测人原发性硬化性胆管炎(PSC)样本中APLN和APJ表达及血清APLN水平。
- 雄性野生型(WT)小鼠行胆管结扎(BDL)或假手术后,用ML221(APJ拮抗剂)或生理盐水处理1周。
- WT和APLN-/-小鼠行BDL或假手术1周。
- 多药耐药基因2敲除(Mdr2-/-)小鼠用ML221处理1周。
- 体外使用人肝内胆管上皮细胞(HIBEpiCs)和人肝星状细胞系(HHSteCs)研究机制。
主要发现
- PSC样本中APLN血清水平及胆管APLN和APJ表达增加。
- BDL和Mdr2-/-小鼠血清及胆管细胞上清中APLN水平较高。
- ML221处理或APLN-/-减轻BDL诱导和Mdr2-/-诱导的胆管细胞增殖/衰老、肝脏炎症、纤维化和血管生成。
- 体外APLN诱导HIBEpiC增殖,增加Nox4表达、ROS生成和ERK磷酸化。
- ML221、Nox4抑制剂DPI、ROS抑制剂NAC或ERK抑制剂PD98059预处理减少APLN诱导的胆管细胞增殖;APLN诱导HHSteCs活化,NAC可减少该活化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Apelin (APLN) is the endogenous ligand of its G protein-coupled receptor, apelin receptor (APJ). APLN serum levels are increased in human liver diseases. We evaluated whether the APLN-APJ axis regulates ductular reaction and liver fibrosis during cholestasis. APPROACH AND RESULTS: We measured the expression of APLN and APJ and serum APLN levels in human primary sclerosing cholangitis (PSC) samples. Following bile duct ligation (BDL) or sham surgery, male wild-type (WT) mice were treated with ML221 (APJ antagonist) or saline for 1 week. WT and APLN-/- mice underwent BDL or sham surgery for 1 week. Multidrug resistance gene 2 knockout (Mdr2-/- ) mice were treated with ML221 for 1 week. APLN levels were measured in serum and cholangiocyte supernatants, and cholangiocyte proliferation/senescence and liver inflammation, fibrosis, and angiogenesis were measured in liver tissues. The regulatory mechanisms of APLN-APJ in (1) biliary damage and liver fibrosis were examined in human intrahepatic biliary epithelial cells (HIBEpiCs) treated with APLN and (2) hepatic stellate cell (HSC) activation in APLN-treated human HSC lines (HHSteCs). APLN serum levels and biliary expression of APLN and APJ increased in PSC samples. APLN levels were higher in serum and cholangiocyte supernatants from BDL and Mdr2-/- mice. ML221 treatment or APLN-/- reduced BDL-induced and Mdr2-/- -induced cholangiocyte proliferation/senescence, liver inflammation, fibrosis, and angiogenesis. In vitro, APLN induced HIBEpiC proliferation, increased nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) expression, reactive oxygen species (ROS) generation, and extracellular signal-regulated kinase (ERK) phosphorylation. Pretreatment of HIBEpiCs with ML221, diphenyleneiodonium chloride (Nox4 inhibitor), N-acetyl-cysteine (NAC, ROS inhibitor), or PD98059 (ERK inhibitor) reduced APLN-induced cholangiocyte proliferation. Activation of HHSteCs was induced by APLN but reduced by NAC. CONCLUSIONS: The APLN-APJ axis induces cholangiocyte proliferation through Nox4/ROS/ERK-dependent signaling and HSC activation through intracellular ROS. Modulation of the APLN-APJ axis may be important for managing cholangiopathies.
引用
- Chen L, Zhou T, White T, et al. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis. Hepatology. 2021. PMID: 32964473. doi:10.1002/hep.31545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。